Supreme Court’s Copaxone Ruling Could Increase Expert Witness Testimony
This article was originally published in The Pink Sheet Daily
Executive Summary
High court rules Federal Circuit should have granted deference to district court’s decision on meaning of Copaxone patent claim; Federal Circuit must now reconsider its finding that the patent is invalid.